DanCann Pharma's CEO Jeppe Krog Rasmussen presents in BioStock's studio
| Published November 2, 2022

BioStock Investor Pitch: DanCann Pharma

Danish pharmaceutical company DanCann Pharma's goal is to improve the lives of patients by providing medical cannabis and cannabinoids. Earlier this year, the company signed an agreement with

WEECO Pharma worth DKK 40 million and expects to reach its commercial breakthrough in the near future. To finance the next step in its development, it is now carrying out a share issue of DKK 28,5 million.

Se DanCann Pharmas vd Jeppe Krog Rasmussen present the company, in English, below.